Stay updated on Johnson & Johnson Press Releases

Sign up to get notified when there's something new on the Johnson & Johnson Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Johnson & Johnson Press Releases page

  1. Check
    2 days ago
    Change Detected
    Summary
    New February 2026 press releases and other recent headlines have been added to the listing. The total results count updated to 2,234 and several January 2026 releases were removed from the page.
    Difference
    8%
    Check dated 2026-02-03T22:40:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The listing now includes new entries dated January 27, 2026 and January 21, 2026 (including a $100 million medtech donation and a Q4/Full-Year 2025 results post), and the total results count updates to 2,228; older items such as the January 6, 2026 EMA submission for TECVAYLI and Nipocalimab SLE data are removed.
    Difference
    7%
    Check dated 2026-01-27T17:00:33.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    New press releases were added for January 16-6, 2026, including CAPLYTA data, the Arbrea Breast Simulator app, TECVAYLI results, leadership updates, and other January 2026 items. Older items like the January 2, 2026 dividend announcement and December 2025 regulatory news were removed.
    Difference
    7%
    Check dated 2026-01-20T02:49:27.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    New January 2026 press releases were added to the listing (e.g., RYBREVANT longer-term results, government agreement to lower costs, OTTAVA robotic system, TECVAYLI combination, Nipocalimab SLE data). The total results count expanded from 2,217 to 2,223 and older items were removed.
    Difference
    7%
    Check dated 2026-01-13T01:22:31.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    2,217 results are shown (up from 2,215), and new entries such as the January 2, 2026 dividend announcement and December 29, 2025 Halda Therapeutics acquisition were added. A detailed MajesTEC-3 TECVAYLI/DARZALEX FASPRO results description was removed.
    Difference
    7%
    Check dated 2026-01-05T09:27:19.000Z thumbnail image
  6. Check
    39 days ago
    Change Detected
    Summary
    New press releases were added on December 26, 2025 and December 22, 2025, including a Phase 2b DUPLEX-AD study statement and a pediatric TREMFYA approval. Older releases from December 6 and December 5, 2025 were removed, and the total results count updated to 2,215.
    Difference
    7%
    Check dated 2025-12-29T03:29:48.000Z thumbnail image

Stay in the know with updates to Johnson & Johnson Press Releases

Enter your email address, and we'll notify you when there's something new on the Johnson & Johnson Press Releases page.